Galecto, Inc.（GLTO）内部人交易：高管与董事近期交易
过去 18 个月，共有 11 位内部人为 Galecto, Inc.（GLTO）报告了 25 笔 Form 4 交易（最近一笔 2026-02-12）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-02-12 | Bruno Julianne | 董事 | 买入 | 129,000 | $0 |
| 2026-02-12 | Harwin Peter Evan | 董事 | 买入 | 5.8M | $0 |
| 2026-02-12 | Fairmount Healthcare Fund II L.P. | 10% 以上股东 | 买入 | 5.8M | $0 |
| 2026-02-12 | Fairmount Funds Management LLC | 董事 | 买入 | 5.8M | $0 |
| 2026-02-12 | Kiselak Tomas | 10% 以上股东 | 买入 | 5.8M | $0 |
| 2026-02-12 | Fairmount Healthcare Co-Invest V L.P. | 10% 以上股东 | 买入 | 5.8M | $0 |
| 2026-02-12 | Harwin Peter Evan | 董事 | 买入 | 2.9M | $0 |
| 2026-02-12 | Fairmount Healthcare Fund II L.P. | 10% 以上股东 | 买入 | 2.9M | $0 |
| 2026-02-12 | Fairmount Funds Management LLC | 董事 | 买入 | 2.9M | $0 |
| 2026-02-12 | Kiselak Tomas | 10% 以上股东 | 买入 | 2.9M | $0 |
| 2026-02-12 | Fairmount Healthcare Co-Invest V L.P. | 10% 以上股东 | 买入 | 2.9M | $0 |
| 2026-01-26 | Sattarzadeh Sherwin | Chief Operating Officer | 买入 | 190,376 | $0 |
| 2026-01-07 | Hewes L. Becker | Chief Medical Officer | 买入 | 264,629 | $0 |
| 2026-01-06 | Firmani Lori | Chief Financial Officer | 买入 | 374 | $0 |
| 2026-01-06 | Firmani Lori | Chief Financial Officer | 卖出 | 135 | $2,890 |
| 2026-01-06 | Schambye Hans T. | Chief Executive Officer | 买入 | 1,360 | $0 |
| 2026-01-06 | Schambye Hans T. | Chief Executive Officer | 卖出 | 700 | $14,966 |
| 2026-01-06 | Winslow Garrett | General Counsel | 买入 | 680 | $0 |
| 2026-01-06 | Winslow Garrett | General Counsel | 卖出 | 255 | $5,452 |
| 2025-07-08 | Firmani Lori | Interim CFO | 买入 | 374 | $0 |
| 2025-07-08 | Firmani Lori | Interim CFO | 卖出 | 147 | $498 |
| 2025-07-08 | Schambye Hans T. | Chief Executive Officer | 买入 | 1,360 | $0 |
| 2025-07-08 | Schambye Hans T. | Chief Executive Officer | 卖出 | 735 | $2,484 |
| 2025-07-08 | Winslow Garrett | General Counsel | 买入 | 680 | $0 |
| 2025-07-08 | Winslow Garrett | General Counsel | 卖出 | 260 | $881 |
来源：SEC Form 4 申报文件 · 截至 2026-02-12